Last $50.13 USD
Change Today +0.09 / 0.18%
Volume 73.2K
IART On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 09/29/14 All times are local (Market data is delayed by at least 15 minutes).

integra lifesciences holding (IART) Snapshot

Open
$49.59
Previous Close
$50.04
Day High
$50.22
Day Low
$49.10
52 Week High
08/25/14 - $51.32
52 Week Low
09/30/13 - $39.34
Market Cap
1.6B
Average Volume 10 Days
161.4K
EPS TTM
$1.78
Shares Outstanding
32.6M
EX-Date
--
P/E TM
28.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for INTEGRA LIFESCIENCES HOLDING (IART)

Related News

No related news articles were found.

integra lifesciences holding (IART) Related Businessweek News

No Related Businessweek News Found

integra lifesciences holding (IART) Details

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone, including demineralized bone products, collagen ceramic matrices, and synthetic bone grafting solutions; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. In addition, it provides extremity products, including bone and joint fixation devices, implants and instruments for osteoarthritis, rheumatoid arthritis, wrist and shoulder arthroplasty, carpal tunnel syndrome, and cubital tunnel syndrome, as well as regenerative medicine devices for the treatment of acute and chronic wounds, peripheral nerve repair and protection and tendon repair, and bone graft substitutes. Further, the company offers instruments products, such as specialty and general surgical and dental instruments; and surgical lighting for hospitals, outpatient surgery centers, and physician, veterinarian, and dental practices. Integra LifeSciences Holdings Corporation sells its products directly through various sales forces and distribution channels in the United States and internationally. The company was founded in 1989 and is headquartered in Plainsboro, New Jersey.

3,300 Employees
Last Reported Date: 02/27/14
Founded in 1989

integra lifesciences holding (IART) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $787.1K
Head of Strategic Development, Corporate Vice...
Total Annual Compensation: $336.6K
President of Neurosurgery and Corporate Vice ...
Total Annual Compensation: $335.1K
Chief Administrative Officer and Corporate Vi...
Total Annual Compensation: $549.4K
Corporate Vice President, General Counsel, Ad...
Total Annual Compensation: $355.7K
Compensation as of Fiscal Year 2013.

integra lifesciences holding (IART) Key Developments

Integra LifeSciences Announces Full Market Release for the Integra(R) Freedom Wrist Arthroplasty System

Integra LifeSciences Holdings Corporation announced the full commercial release of the Integra(R) Freedom Wrist Arthroplasty System in the United States. The system, which is used in the treatment of wrist arthritis, has been successfully implanted in a limited release in 21 patients, during the summer months. The Freedom Wrist features advanced implant design and enhanced instrumentation to aid in efficient and potentially more reproducible surgical results. The introduction of the Freedom Wrist rounds out one of the most comprehensive wrist arthritis solutions portfolio in the industry.

Integra LifeSciences Holdings Corporation Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-09-2014 10:35 AM

Integra LifeSciences Holdings Corporation Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-09-2014 10:35 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Glenn G. Coleman, Chief Financial Officer, Principal Accounting Officer and Corporate Vice President, Peter J. Arduini, Chief Executive Officer, President, Director and Member of Special Award Committee.

Brian Larkin to Retire as Corporate Vice President, President Global Spine and Orthobiologics, and Head of Strategic Development of Integra LifeSciences Holdings Corporation

On August 19, 2014, Integra LifeSciences Holdings Corporation announced that Brian Larkin, Corporate Vice President, President Global Spine and Orthobiologics, and Head of Strategic Development, will retire from the company by the end of 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IART:US $50.13 USD +0.09

IART Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chemed Corp $104.11 USD +1.59
CONMED Corp $37.83 USD +0.43
Globus Medical Inc $19.64 USD +0.19
Masimo Corp $21.07 USD -0.02
NuVasive Inc $35.02 USD -0.14
View Industry Companies
 

Industry Analysis

IART

Industry Average

Valuation IART Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 2.4x
Price/Cash Flow 245.2x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTEGRA LIFESCIENCES HOLDING, please visit www.integralife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.